1-31579228-A-C
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The ENST00000271064.12(TINAGL1):āc.335A>Cā(p.Tyr112Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000104 in 1,613,974 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (ā ). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. Y112F) has been classified as Uncertain significance.
Frequency
Consequence
ENST00000271064.12 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TINAGL1 | NM_022164.3 | c.335A>C | p.Tyr112Ser | missense_variant | 3/12 | ENST00000271064.12 | NP_071447.1 | |
LOC105378626 | XR_007065603.1 | n.316T>G | non_coding_transcript_exon_variant | 1/7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TINAGL1 | ENST00000271064.12 | c.335A>C | p.Tyr112Ser | missense_variant | 3/12 | 1 | NM_022164.3 | ENSP00000271064 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000723 AC: 11AN: 152130Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000835 AC: 21AN: 251446Hom.: 0 AF XY: 0.0000809 AC XY: 11AN XY: 135894
GnomAD4 exome AF: 0.000107 AC: 157AN: 1461844Hom.: 0 Cov.: 30 AF XY: 0.000110 AC XY: 80AN XY: 727224
GnomAD4 genome AF: 0.0000723 AC: 11AN: 152130Hom.: 0 Cov.: 32 AF XY: 0.0000942 AC XY: 7AN XY: 74298
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 02, 2022 | The c.335A>C (p.Y112S) alteration is located in exon 3 (coding exon 2) of the TINAGL1 gene. This alteration results from a A to C substitution at nucleotide position 335, causing the tyrosine (Y) at amino acid position 112 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at